Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04831333
Other study ID # 20210331001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2021
Est. completion date May 1, 2021

Study information

Verified date July 2021
Source Beijing YouAn Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Ophthalmological screening for cytomegalovirus retinitis (CMVR) for HIV/AIDS patients is important. However, the manual screening with fundus imaging is laborious and subjective. Deep learning (DL) system has been developed for the automated detection of various eye diseases with high accuracy and efficiency, including diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), papilledema, lattice degeneration and retinal breaks, from ocular fundus photographs. UWF imaging is a relatively new imaging modality for DL system but has also shown extraordinary talents in automatic retinal analysis With the press for routine CMVR screening in AIDS patients and the great capacity of DL system, the use of deep learning (DL) system to AIDS-related CMVR with Ultra-Widefield (UWF) fundus images is promising. The investigators previously developed a DL system to detect AIDS-related CMVR. For further evaluating the applicability of the DL system, a prospective dataset is needed.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 1, 2021
Est. primary completion date May 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: The UWF images from HIV/AIDS patients. Exclusion Criteria: 1. The UWF images would be excluded if all three human graders gave different diagnosis. 2. The UWF images with poor quality would be excluded.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Beijing Youan Hospital, Capital Medical University Beijing Beijing

Sponsors (2)

Lead Sponsor Collaborator
Kuifang Du Beijing Tongren Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluating the applicability of the DL system to identify AIDS-related CMVR The investigators compared the performance between two trained (senior and junior) retinal ophthalmologists with the DL system. A senior retinal ophthalmologist and a junior retinal ophthalmologist were asked to independently screen the UWF images in the prospective dataset. Accuracy, sensitivity and specificity were used to evaluate the performance. April 2021
See also
  Status Clinical Trial Phase
Completed NCT00000135 - Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Phase 2/Phase 3
Completed NCT00000118 - Ganciclovir Implant Study for Cytomegalovirus Retinitis Phase 3
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT00000143 - Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Phase 3
Completed NCT01866397 - Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Phase 4
Completed NCT00004794 - Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis Phase 2
Completed NCT00000136 - Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Phase 3
Completed NCT00091884 - Efficacy of Elevated CD4 Counts on CMV Retinitis N/A
Recruiting NCT05911503 - Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis Early Phase 1
Completed NCT00002377 - A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Phase 3
Completed NCT00001611 - Immune Activity Against CVM Retinitis N/A
Completed NCT00000134 - Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Phase 3
Completed NCT00000168 - Longitudinal Study of Ocular Complications of AIDS (LSOCA) N/A
Active, not recruiting NCT00017784 - Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Phase 3
Active, not recruiting NCT00002384 - A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS N/A
Active, not recruiting NCT00002301 - A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir N/A
Completed NCT00002016 - A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis Phase 1
Completed NCT00002321 - A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis Phase 1
Completed NCT00002125 - A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Phase 4
Completed NCT00002330 - A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS N/A